 |
 |
 |
 |
 |
 |
 |
 |
-
BROWSE TOPICS IN CLINICAL MANAGEMENT:
Antiretroviral Therapy- Complications of HIV/HAART
- Research & Development
- Clinical Trials
- Quality of Life & Patient Care
Antiretroviral Therapy
Preventive HIV Vaccines
Overview
- Statement of Anthony S. Fauci, M.D., on HIV Vaccine Awareness Day (May 18, 2008)
From National Institute of Allergy and Infectious Diseases - 2008 AVAC Report The Search Must Continue (May 2008)
From AIDS Vaccine Advocacy Coalition - Scientists No Closer to Developing HIV Vaccine Than 20 Years Ago, AAAS President Says (February 19, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - An Update Regarding the HVTN 502 and HVTN 503 HIV Vaccine Trials (October 23, 2007)
From U.S. National Institute of Allergy and Infectious Diseases - Questions and Answers: HVTN 502 and HVTN 503 HIV Vaccine Clinical Trials (October 23, 2007)
From U.S. National Institute of Allergy and Infectious Diseases - Researchers Examine Effect of Failed HIV Vaccine (October 9, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - NIAID Statement on HIV Vaccine Awareness Day (May 18, 2007)
From U.S. National Institute of Allergy and Infectious Diseases - The Quest for an Effective HIV Vaccine Presents New Possibilities, Challenges (May 16, 2007)
From U.S. National Institute of Allergy and Infectious Diseases - NIAID Statement on HIV Vaccine Awareness Day, May 18, 2006 (May 15, 2006)
Dr. Anthony Fauci and colleagues urge greater funding and support for vaccine development.
From U.S. National Institute of Allergy and Infectious Diseases - Leading HIV Vaccine Researcher Emilio Emini Leaves International AIDS Vaccine Initiative for Wyeth (November 4, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Even an Imperfect HIV Vaccine Can Save Millions of Lives, Report Says (PDF) (October 2005)
From International AIDS Vaccine Initiative - Preventive Technologies Pipeline: Vaccines (September 29, 2005)
In TAGline, from Treatment Action Group - Why Does an Effective HIV Vaccine Remain Elusive? (August 25, 2005)
University of Michigan Medical School professor Howard Markel, M.D., Ph.D., explains some of the roadblocks.
In New England Journal of Medicine - Survey Uncovers Surprising Attitudes Towards HIV Vaccine Research (August 8, 2005)
Widespread misconceptions about HIV vaccines; most Americans support vaccine research, but do not support vaccine study participation.
From U.S. National Institute of Allergy and Infectious Diseases - Science Magazine Examines Feasibility of HIV Vaccine (July 5, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Health Care Professionals: Answers About HIV Vaccine Research (January 2005)
To read PDF, click here
From U.S. National Institute of Allergy and Infectious Diseases - Challenges in Designing HIV Vaccines (May 2004)
From U.S. National Institute of Allergy and Infectious Diseases - Interview With Peggy Johnston, Ph.D., on the Current State of Vaccine Research (Spring 2004)
Dr. Johnston is the Director of AIDS Vaccine Research and Prevention at NIAID.
In Positives for Positives, from Wyoming: Positives for Positives - Understanding Vaccines: What They Are, How They Work (PDF) (July 2003)
From National Institute of Allergy and Infectious Diseases - Hope in a Vial: Will There Be an HIV Vaccine Anytime Soon? (June 2002)
In Scientific American - Effective AIDS Vaccine Probably at Least a Decade Away, Researcher Says (March 18, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - HIV 101: HIV Vaccine Candidates (October 2001)
To read PDF, click here
In HEPP News, from Brown Medical School - AIDS Vaccines: The Ethical and Social Issues (Summer 2001)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation - Policy Issues in AIDS Vaccine Development (February 2001)
A clinical overview from an online textbook of HIV disease from the University of California San Francisco and San Francisco General Hospital.
From HIV InSite - HIV Vaccine Glossary (May 2000)
From U.S. National Institute of Allergy and Infectious Diseases
Clinical Trials
- International AIDS Vaccine Research Database of AIDS Vaccines in Human Trials (Regularly Updated)
From International AIDS Vaccine Initiative - Seattle Post-Intelligencer Examines Reactions of People Who Participated in Merck's Canceled HIV Vaccine Trial (November 12, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - NIH Launches Phase II Trial of HIV Vaccine for Three Strains of Virus (October 12, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Most in U.S. Hopeful About Development of HIV Vaccine, but Many Fear Participation in Trials, Study Shows (August 9, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Indian Government Approves Another HIV Vaccine for Phase I Clinical Trial (July 18, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - India Begins Phase I Clinical Trial for HIV Vaccine Targeting C Strain (February 8, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - NIAID Begins Enrolling Volunteers for Novel HIV Vaccine Study (January 24, 2005)
A news release announcing the launch of this Phase II trial, called the Step Study; worldwide study locations and eligibility criteria are listed.
From U.S. National Institute of Allergy and Infectious Diseases - Timeline for the Initiation of the RV144 Prime-Boost Trial (January 2005)
In TAGline, from Treatment Action Group - Treatment Action Group Criticizes U.S.-Sponsored RV144 ALVAC/AIDSVAX "Prime-Boost" Vaccine Trial in Thailand (September 28, 2004)
In TAGline, from Treatment Action Group - One Step Forward: Merck Vaccine Moves Forward With Efficacy Trial, While Special Committee Tries to Salvage Thai Study (July 2004)
In TAGline, from Treatment Action Group - ADVAX, New DNA Vaccine in Human Trial; HIV-Negative Volunteers Needed in New York City or Rochester, NY Areas (June 30, 2004)
In AIDS Treatment News, from AIDS Treatment News - Group of Scientists Questions Value, Cost of Federally Funded AIDS Vaccine Trial in Thailand (January 16, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - U.S. Government Defends RV 144, an Ongoing HIV Vaccine Efficacy Trial in Thailand (January 15, 2004)
From U.S. National Institute of Allergy and Infectious Diseases - The Diabolic Science: VaxGen's Claims of Vaccine Efficacy Evanesce in Autumn's Last Light (October 2003)
Further analysis of AIDSVAX's efficacy -- or lack thereof -- in minorities.
In TAGline, from Treatment Action Group - Merck HIV Vaccines Progress Through Safety Trials (September 2, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - South Africa's Medicines Control Council Approves Country's Second HIV Vaccine Clinical Trial (August 27, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - U.S. Company Denies Plan to Abandon AIDS Vaccine Test in Thailand (July 7, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Race Is On to Save the First AIDS Vaccine. But Does It Even Work? (July 1, 2003)
VaxGen pulls out of a final set of trials for its AIDSVAX vaccine amid claims of hype and manipulation.
In The Guardian - South Africa to Test First Vaccine Against HIV Subtype C (June 20, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Italian HIV Vaccine Trial Ready to Begin (June 5, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Australian-Developed HIV Vaccine Trial Announced (June 4, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Trials of AIDS Vaccine to Start in India (May 12, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Against the Odds, Company Works on AIDS Vaccine (November 22, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - First Human Trial of "Global" HIV Vaccine Launched (November 18, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - New HIV Vaccine Holds Promise of Global Effectiveness (November 13, 2002)
From U.S. National Institutes of Health - Clinical Trials of India-Specific Anti-AIDS Vaccine to Start in 2003 (April 22, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Arizonans to Take Part in Study for an AIDS Vaccine (March 26, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Albany-Area AIDS Vaccine Testers Needed for Study at Albany Medical College (March 19, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Maryland: Institute of Human Virology Plans Clinical Trial of AIDS Vaccine (March 14, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - NIAID Phase III HIV Vaccine Trial in the United States Will Not Proceed (March 11, 2002)
Further explanation for why one of the U.S. government's two vaccine trials is being called off.
To read PDF, click here
In STEP Ezine, from Seattle Treatment Education Project - NIAID Phase III HIV Vaccine Trial to Determine Correlates of Protection Will Not Proceed (February 25, 2002)
Phase III trial in Thailand to determine efficacy will be supported by NIAID through a combined NIAID-DoD program.
From U.S. National Institute of Allergy and Infectious Diseases - First AIDS Vaccine Made at NIAID's Vaccine Research Center Enters Clinical Trial (October 9, 2001)
From National Institute of Allergy and Infectious Diseases - Vaccine Advance: Merck Makes Surprise Announcement of Human Vaccine Trial, Currently Underway (March 2001)
In TAGline, from Treatment Action Group - First HIV Vaccine for Africa Begins Trials (January 26, 2001)
In AIDS Treatment News, from AIDS Treatment News - New Oral DNA Vaccine Funded for Trials (June 2, 2000)
A new kind of vaccine uses a harmless bacterium to deliver selected parts of HIV to immune cells in the intestinal membranes.
In AIDS Treatment News, from AIDS Treatment News
Initiatives & Recommendations
- TAG's Response to NIAID "Request for Information" on Priorities in Basic HIV Vaccine Research (June 4, 2008)
From Treatment Action Group - PAVE Gives Pause: Position Statement on the Proposed PAVE100A Vaccine Trial (May 30, 2008)
From Treatment Action Group - Updated, Annotated Preventive Vaccine Pipeline Table (May 29, 2008)
Information on the current preventive HIV vaccine pipeline, annotated with commentary and links to published and presented data.
From Treatment Action Group - AIDS and the Next 25 Years (May 9, 2008)
(Free registration required.)
In Science - More Human Clinical Research on HIV Vaccine Needed to Find "Magic Formula," Says Opinion Piece (April 14, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - HIV/AIDS Vaccine Researchers at NIH Meeting Call for Increase in Basic Research, New Strategies (March 26, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - U.S. Should Fund HIV/AIDS Strategies "That Work," Not "Expensive Vaccine Research," Opinion Piece Says (March 25, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Gates Foundation, Canadian Government Announce Joint Initiative to Develop HIV/AIDS Vaccine (February 21, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - NIAID Announces New Campaign to Raise Awareness of Preventive HIV Vaccine Research (October 11, 2006)
From National Institute of Allergy and Infectious Diseases - Gates Foundation Pledges $287 Million for HIV Vaccine Research (July 20, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - World Risks Duplication in AIDS Vaccine Push, International AIDS Vaccine Initiative Official Says (September 14, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Canadian Network of Vaccine Researchers' National Funding Grant Not Renewed (July 20, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - NIAID Establishes Consortium to Research, Develop HIV Vaccines (July 18, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - NIAID Funds Center for HIV/AIDS Vaccine Immunology (July 14, 2005)
From U.S. National Institute of Allergy and Infectious Diseases - U.S. Spurs New Initiative on Vaccine Development -- But Some Critics Are Worried (June 15, 2004)
From MotherJones.com - G8 Countries Agree to Form Global HIV Vaccine Consortium (June 14, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Interview With Anthony Fauci, M.D., Director of NIAID, on the HIV Vaccine Enterprise (Summer 2004)
An unofficial, international consortium seeks to coordinate vaccine development worldwide.
In Positives for Positives, from Wyoming: Positives for Positives - Merck Vaccine Research Official to Join AIDS Vaccine Initiative (January 13, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - University of Alabama Wins $16 Million Grant to Develop Possible HIV Vaccine (August 12, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - New York Times, Washington Post Examine Vaccine Projects of Bill & Melinda Gates Foundation (July 14, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - VaxGen Granted $2M to Continue HIV Vaccine Research (June 12, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Merck and Aventis Will Combine HIV Vaccines (March 27, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - South African Scientists to Begin Manufacturing New Vaccines Aimed at Preventing AIDS (September 27, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - NIAID Teams With Wyeth on HIV/AIDS Vaccine (May 17, 2002)
From U.S. National Institute of Allergy and Infectious Diseases - HIV Vaccine Research Is "Best Hope" for Controlling AIDS Pandemic (May 16, 2002)
Fifth Annual HIV Vaccine Awareness Day to highlight progress, goals for future.
From U.S. National Institute of Allergy and Infectious Diseases - What's in Glaxo's HIV Vaccine? (March 1, 2002)
In TAGline, from Treatment Action Group - NIAID Phase III HIV Vaccine Trial to Determine Correlates of Protection Will Not Proceed (February 25, 2002)
Phase III trial in Thailand to determine efficacy will be supported by NIAID through a combined NIAID-DoD program.
From U.S. National Institute of Allergy and Infectious Diseases - NIAID and Merck to Collaborate on HIV Vaccine Development (December 20, 2001)
From U.S. National Institute of Allergy and Infectious Diseases - Fauci to Present AIDS Vaccine Update at Philadelphia Meeting (September 4, 2001)
From U.S. National Institute of Allergy and Infectious Diseases - New Prime-Boost HIV Vaccine Strategy Shows Promise in Monkeys (March 8, 2001)
From U.S. National Institute of Allergy and Infectious Diseases - AIDS Research Past and Future: An Interview with Jeffrey Laurence, M.D. (December 2000)
From American Foundation for AIDS Research
Research Findings
- IAVI Report Online (Regularly Updated)
A centralized source of information on all aspects of AIDS vaccine research and associated scientific disciplines.
From International AIDS Vaccine Initiative - Merck HIV Vaccine Trial Results: Hopes Dim for Struggling Field (Winter 2008)
To read PDF, click here
In TAGline, from Treatment Action Group - Leaders of Merck's Canceled HIV Vaccine Study Notify Participants Whether They Received Vaccine, Placebo (November 14, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Merck Halts International HIV Vaccine Trial (September 24, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Vaccination and Enrollment Are Discontinued in Phase II Trials of Merck's Investigational HIV Vaccine Candidate (September 21, 2007)
From Merck & Co., Inc. - Predicting the Impact of a Partially Effective HIV Vaccine and Subsequent Risk Behavior Change on the Heterosexual HIV Epidemic in Low- and Middle-Income Countries: A South African Example (September 1, 2007)
In Journal of Acquired Immune Deficiency Syndromes - AIDS Vaccine Update (July-December 2007)
Disappointment and questions after candidate fails in the STEP study.
In GMHC Treatment Issues, from Gay Men's Health Crisis - Male Circumcision Reduces Men's HIV Infection Risk by 65%, Data Re-Evaluation Says (February 23, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Scientists Unveil Piece of HIV Protein That May Be Key to AIDS Vaccine Development (February 14, 2007)
From U.S. National Institute of Allergy and Infectious Diseases - VAX Primer: Understanding the Early Stages of HIV Infection (April 2006)
How can studying what happens immediately following HIV infection help researchers design an AIDS vaccine?.
From International AIDS Vaccine Initiative - Enrolling Women Into HIV Preventive Vaccine Trials: An Ethical Imperative but a Logistical Challenge (February 21, 2006)
In PLoS Medicine - HIV Vaccine's CD4+ Cell-Boosting Properties Lead Merck to Double Enrollment in Study (September 23, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Most in U.S. Hopeful About Development of HIV Vaccine, but Many Fear Participation in Trials, Study Shows (August 9, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - A Promising Alternative: Preclinical Assessment of HIV Vaccines and Microbicides by Repeated Low-Dose Virus Challenges (August 2005)
A study by researchers at Emory University and Merck.
In PLoS Medicine - Phase I Trial of Italian HIV Vaccine Trial Successful, Researchers Say; Phase II To Test Vaccine in Africa (July 7, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Health Affairs Focuses on Vaccines, Features Interview With Thompson; Kaiser Family Foundation Describes Media Campaigns (May 12, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - International AIDS Vaccine Initiative Releases Several Working Papers, Brief (April 26, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Treble Damages: Three Highlighted Studies From the AIDS Vaccine 2004 Conference (October 2004)
Disappointment clouded this year's conference, with new study results suggesting that current approaches to vaccine development aren't panning out.
In TAGline, from Treatment Action Group - Slow but Real Progress on the AIDS Vaccine Front (September 3, 2004)
Highlights from the AIDS Vaccine 04 conference.
From aidsmap.com - Researchers Identify Mutations That Help HIV Avoid Immune Detection; Implications for Vaccine Development (June 2, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Keystone HIV Pathogenesis and Vaccine Development Report (May/June 2004)
Highlights from the Keystone Symposia on Molecular Mechanisms of HIV Pathogenesis (X7) and HIV Vaccine Development (X8), April 12-18, 2004.
In GMHC Treatment Issues, from Gay Men's Health Crisis - HIV More Vulnerable to Vaccine During Acute Infection, Study Suggests (March 26, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Scientists Find HIV-Blocking Protein in Monkeys (February 25, 2004)
TRIM5-alpha is the first host protein found that specifically targets HIV's capsid.
From U.S. National Institute of Allergy and Infectious Diseases - Researcher Loses HIV Vaccine Data in Durban Mugging (August 6, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Antibody Discovery Could Lead to HIV Vaccine: Study (July 2, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - New HIV Vaccine Shows Promising Results in Preclinical Studies (June 4, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Nabbing the V3 Loop (May 2003)
Susan Zolla-Pazner offers new insight into why some anti-V3 loop antibodies have broad HIV neutralizing ability.
In TAGline, from Treatment Action Group - Starting Anew (Again) (April 2003)
CROI 2003 updates on vaccines, siRNA therapy, CEM15 deactivation and the therapeutic value of GBV-C.
In IAPAC Monthly, from International Association of Physicians in AIDS Care - HIV Evolves More Quickly Than Thought (March 21, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Virion-Based Vaccine Protects Macaques Against SIV (March 19, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - First AIDS Vaccine Tested Did Not Protect, But Gives Scientific Leads (March 14, 2003)
In AIDS Treatment News, from AIDS Treatment News - A Non-Replicating Adenoviral Vector as a Potential HIV Vaccine (Spring 2003)
In Research Initiative/Treatment Action!, from The Center for AIDS - AIDSVAX Arbitrary and Post-Hoc Subset Analysis, Up Close (March 2003)
In TAGline, from Treatment Action Group - Development of a Mouse Model for HIV/AIDS (Spring 2003)
In Research Initiative/Treatment Action!, from The Center for AIDS - Enhancement of Mucosal Immune Responses by Chimeric Influenza HA/SHIV Virus-Like Particles (Spring 2003)
In Research Initiative/Treatment Action!, from The Center for AIDS - Generation of Multivalent Genome-Wide T-Cell Responses in HLA-A*0201 Transgenic Mice by an HIV-1 Expression Library Immunization Vaccine (Spring 2003)
In Research Initiative/Treatment Action!, from The Center for AIDS - Effectiveness of AIDS Vaccine May Be Overstated, Expert Says; Statistics Problem May Account for AIDSVAX Discrepancy (February 27, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Controversial HIV Vaccine Trial Results Disappointing (February 25, 2003)
From Canadian AIDS Treatment Information Exchange - NIAID to Investigate AIDSVAX Research Disparities (February 25, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - First Phase III AIDS Vaccine Largely Ineffective (February 24, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - AIDS Vaccine Unlikely to Give Total Protection From Disease (February 13, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Experimental HIV Vaccine Begins Human Trials (January 27, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - The HIV/AIDS Vaccine Research Effort: An Update (January 2003)
Despite many challenges, a good amount of progress has been made.
In Hopkins HIV Report - Study Examines Willingness to Participate in HIV Vaccine Trial (December 23, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - VaxGen's AIDS Vaccine to Be Reviewed by FDA (December 17, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - HIV Receptor Barrier Helps Explain Vaccine Failures (December 13, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Research From the 42nd ICAAC: Alpha-Defensins, Non-Progressors and Vaccines (December 2002)
In IAPAC Monthly, from International Association of Physicians in AIDS Care - HIV's Success Might Lie in Its Mutations (November 6, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - St. Louis Non-Progressor Still Baffles Researchers (September 25, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Researchers Document Rare Case of Second HIV Infection With Different Strain (September 5, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - HIV-Specific T Cells Tied to Continued Seronegativity in Drug Users (August 26, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - HIV-1 Superinfection: AE Subtype Supplanted by B Subtype (July 11, 2002)
In The XIV International AIDS Conference, from The Body PRO - Hope for AIDS Vaccine Fades; News of Superinfection Case (July 11, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Harnessing the Immune System to Fight HIV (July 10, 2002)
In The XIV International AIDS Conference, from The Body PRO - Immune Responses in Long-Term Non-Progressors -- Lessons for Immune Reconstitution (July 10, 2002)
In The XIV International AIDS Conference, from The Body PRO - Sign of HIV Immunity Reported; Protective Responses Suspected in Two Studies (July 10, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - HIV Selectively Suppresses Anti-HIV Defense Cells (May 1, 2002)
From U.S. National Institute of Allergy and Infectious Diseases - Chimp Adenovirus as New Vaccine Vector (April 9, 2002)
Updates from Retrovirus 2002.
In TAGline, from Treatment Action Group - Franchini's DNA Prime and NYVAC Boost Vaccine (April 9, 2002)
Updates from Retrovirus 2002.
In TAGline, from Treatment Action Group - Not to Be Sneezed At: Merck's HIV Vaccine Program (April 9, 2002)
Updates from Retrovirus 2002.
In TAGline, from Treatment Action Group - AIDS Vaccine Moves Ahead in Trials (April 5, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Effective AIDS Vaccine Probably at Least a Decade Away, Researcher Says (March 18, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - The Impact of Partially Effective HIV Vaccine on a Population of Intravenous Drug Users in Bangkok, Thailand: A Dynamic Model (March 7, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Riddle Women: Reports of Progress Toward Understanding How Some People Appear to Fight Off HIV (November 2001)
In TAGline, from Treatment Action Group - Vaccine Stops Vaginal Transmission of HIV-Like Virus (July 23, 2001)
From Reuters Health - Simian Success (January 2001)
Vaccine study seen as significant advance, but questions remain about human applicability.
In TAGline, from Treatment Action Group - Status Report on HIV Vaccine Development (Winter 2000)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
Advocacy
- Vaccine Trial RV144 Squanders Public Goodwill and Scarce Research Funds -- But to What End? (January 2005)
An AIDS advocacy group questions the wisdom of RV144, an ongoing "prime-boost" Phase III vaccine trial in Thailand.
In TAGline, from Treatment Action Group - Seventh Annual HIV Vaccine Awareness Day Highlights Slow Progress on Development (May 18, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Top HIV/AIDS Researchers Push for Greater Vaccine Effort (June 27, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - International HIV Vaccine Awareness Day: May 18, 2003 (May 16, 2003)
From U.S. National Institute of Allergy and Infectious Diseases - Many Americans Think an HIV/AIDS Vaccine Already Exists (May 15, 2003)
From U.S. National Institute of Allergy and Infectious Diseases
  |
  |